Milrinone or Dobutamine for Cardiogenic Shock?

September 27, 2021 00:25:40
Milrinone or Dobutamine for Cardiogenic Shock?
Critical Care Perspectives in Emergency Medicine
Milrinone or Dobutamine for Cardiogenic Shock?

Sep 27 2021 | 00:25:40

/

Show Notes

Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.  Which agent was the winner?

You can get CME credit for this episode hereClick here for CME Account Creation Instructions

Other Episodes

Episode

July 01, 2021 00:26:54
Episode Cover

The TTM2 Trial

Current international guidelines recommend TTM for adult patients with ROSC from OHCA who remain comatose or unable to follow verbal commands.  However, the overall...

Listen

Episode

January 26, 2021 00:22:57
Episode Cover

The Critically Ill Patient with Aortic Stenosis

Patients with severe aortic stenosis who present with acute decompensated heart failure are among the most challenging patients to resuscitate.  In this podcast, we...

Listen

Episode

May 13, 2020 00:21:18
Episode Cover

COVID-19: Toxicities of Potential Therapies

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence....

Listen